Clarke S - Search Results

1

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

Li BT, Shen R, Buonocore D, Olah ZT, Ni A, Ginsberg MS, Ulaner GA, Offin M, Feldman D, Hembrough T, Cecchi F, Schwartz S, Pavlakis N, Clarke S, Won HH, Brzostowski EB, Riely GJ, Solit DB, Hyman DM, Drilon A, Rudin CM, Berger MF, Baselga J, Scaltriti M, Arcila ME, Kris MG. Li BT, et al. Among authors: clarke s. J Clin Oncol. 2018 Aug 20;36(24):2532-2537. doi: 10.1200/JCO.2018.77.9777. Epub 2018 Jul 10. J Clin Oncol. 2018. PMID: 29989854 Free PMC article. Clinical Trial.

2

Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Clarke SJ, Abratt R, Goedhals L, Boyer MJ, Millward MJ, Ackland SP. Clarke SJ, et al. Ann Oncol. 2002 May;13(5):737-41. doi: 10.1093/annonc/mdf115. Ann Oncol. 2002. PMID: 12075742 Free article. Clinical Trial.

3

Gefitinib in advanced non-small cell lung cancer.

Sharma R, Boyer M, Clarke S, Millward M. Sharma R, et al. Among authors: clarke s. Intern Med J. 2005 Feb;35(2):77-82. doi: 10.1111/j.1445-5994.2005.00776.x. Intern Med J. 2005. PMID: 15705135

4

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzén F, Cassidy J. Saltz LB, et al. Among authors: clarke s. J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930. J Clin Oncol. 2008. PMID: 18421054 Corrected and republished. Clinical Trial.

5

Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial.

Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D. Oh B, et al. Among authors: clarke s. Ann Oncol. 2010 Mar;21(3):608-614. doi: 10.1093/annonc/mdp479. Epub 2009 Oct 30. Ann Oncol. 2010. PMID: 19880433 Free PMC article. Clinical Trial.

6

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ. Kao SC, et al. Clin Cancer Res. 2010 Dec 1;16(23):5805-13. doi: 10.1158/1078-0432.CCR-10-2245. Epub 2010 Oct 18. Clin Cancer Res. 2010. PMID: 20956618

7

The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia.

Oh B, Butow P, Mullan B, Beale P, Pavlakis N, Rosenthal D, Clarke S. Oh B, et al. Among authors: clarke s. Asia Pac J Clin Oncol. 2010 Dec;6(4):342-9. doi: 10.1111/j.1743-7563.2010.01329.x. Epub 2010 Oct 26. Asia Pac J Clin Oncol. 2010. PMID: 21114784

8

The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine.

Kao SC, Harvie R, Paturi F, Taylor R, Davey R, Abraham R, Clarke S, Marx G, Cullen M, Kerestes Z, Pavlakis N. Kao SC, et al. Among authors: clarke s. Lung Cancer. 2012 Feb;75(2):248-54. doi: 10.1016/j.lungcan.2011.06.007. Epub 2011 Jul 16. Lung Cancer. 2012. PMID: 21757252

9

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S. Kao SC, et al. Among authors: clarke c, clarke s. Clin Lung Cancer. 2013 Jan;14(1):70-7. doi: 10.1016/j.cllc.2012.03.011. Epub 2012 Jun 1. Clin Lung Cancer. 2013. PMID: 22658812

10

A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer.

Michael M, Pavlakis N, Clingan P, De Boer R, Johnston M, Clarke S. Michael M, et al. Among authors: clarke s. Oncol Rep. 2012 Sep;28(3):763-7. doi: 10.3892/or.2012.1871. Epub 2012 Jun 15. Oncol Rep. 2012. PMID: 22710607 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,782 results

Search Page